Arineta proudly claims that the SpotLight programs are the newest addition to their legacy of medical innovation (
Arineta’s CEO, Scott Schubert, emphasizes the corporate’s imaginative and prescient, stating, “Our imaginative and prescient is to develop cardiac CT because the front-line non-invasive check for diagnosing, remedy planning, and monitoring of heart problems, the primary explanation for dying and healthcare prices worldwide.”
SpotLight Duo: Elevating Cardiac Imaging
Along with the SpotLight system, Arineta introduces the SpotLight Duo, which takes cardiovascular imaging to the subsequent degree. This superior know-how supplies complete organ acquisition with 4D imaging, enabling enhanced visualization of vascular stream and organ movement.
With 45 cm high-resolution scans, the SpotLight Duo facilitates complete cardiothoracic CT assessments, masking a spread of situations, from lung most cancers and COVID-19 to different pulmonary illnesses.
With FDA clearance now in place, the SpotLight and SpotLight Duo CT scanners are poised to empower healthcare professionals with superior instruments for cardiovascular assessments.
These cutting-edge scanners goal to boost the accuracy, effectivity, and effectiveness of diagnosing and monitoring cardiovascular illnesses, marking a major development within the area of cardiac care.
- FDA Clears First Main Imaging Gadget Development for Computed Tomography in Almost a Decade – (https:www.fda.gov/news-events/press-announcements/fda-clears-first-major-imaging-device-advancement-computed-tomography-nearly-decade)